# Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection

> **NCT04621487** · NA · COMPLETED · sponsor: **University of Split, School of Medicine** · enrollment: 80 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Metronidazole
- **DRUG:** Clarithromycin
- **DRUG:** Pantoprazole 40mg
- **DRUG:** according to antibiogram

## Key facts

- **NCT ID:** NCT04621487
- **Lead sponsor:** University of Split, School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2020-01-15
- **Final completion:** 2020-02-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621487, "Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04621487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*